Evidence map›Paper›PMID 40921151›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2026

A Real-World Cohort Study of the Risks of Kidney Failure and Death in Diabetes.

Katherine R Tuttle, Lindsey M Kornowske, Cami R Jones, Christina L Reynolds, Radica Z Alicic, Kenn B Daratha, Joshua J Neumiller, O Kenrik Duru, Susanne B Nicholas, Keith C Norris and 2 more

Abstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Kidney and Survival Outcomes with Semaglutide by CKD Severity in the FLOW Trial.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Katherine R TuttleProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington.ORCID 0000-0002-2235-0103
Lindsey M KornowskeProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington.
Cami R JonesProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington.
Christina L ReynoldsProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington.
Radica Z AlicicProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington.ORCID 0000-0002-5437-5700
Kenn B DarathaProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington.ORCID 0000-0002-9194-4140
Joshua J NeumillerProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington.ORCID 0000-0002-4734-7402
O Kenrik DuruDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, California.
Susanne B NicholasDivision of Nephrology, David Geffen School of Medicine, University of California, Los Angeles, California.ORCID 0000-0003-3535-9120
Keith C NorrisDivision of Nephrology, David Geffen School of Medicine, University of California, Los Angeles, California.ORCID 0000-0003-3071-0700
Meda E PavkovDivision of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia.
CURE-CKD Consortium

Funding

CDC HHS 75D301-21-P-12254CDC HHS 75D301-23-C-18264
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diabeteskidney failuremortality risk

Identifiers

PMID40921151
PMCPMC13135045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.